Comparative Effects of Conventional Physical Therapy, Kinesio Taping and ESWT in Upper Trapezius MPS.

Trapezius Muscle Strain Clinical Trial

Official title:

Comparative Effects of Conventional Physical Therapy, Kinesio Taping and Extracorporeal Shock Wave Therapies in Upper Trapezius Myofascial Pain Syndrome.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05277259
• Other study ID #: van yyü university
• Status: Completed
• Phase: N/A
• Start date: April 4, 2022
• Est. completion date: May 2, 2022

Study information

• Verified date: May 2022
• Source: Yuzuncu Yil University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

There is no study in the literature comparing both kinesiotaping and Extracorporeal Shock Wave Therapy (ESWT) with conventional physical therapy in upper trapezius myofascial pain syndrome. In this study, we aimed to make this comparison.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 99
• Est. completion date: May 2, 2022
• Est. primary completion date: April 18, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Presence of at least 1 active trigger point in the upper trapezius muscle, exacerbation of pain when this point(s) is pressed, painful limitation of cervical lateral flexion and extension.

Exclusion Criteria:

• Having a history of spine and upper extremity surgery, neuromuscular disease, active rheumatologic disease, active infection, malignancy, having previously applied ESWT or Kinesio Taping to the back and neck region.

Related Conditions & MeSH terms

• Sprains and Strains
• Trapezius Muscle Strain

Intervention

Device:
• Extracorporeal Shock Wave Therapy
Device named 'Elettronica Pagani,Italy' and will be used with radial probe.

Other:
• Kinesiotaping
Elastic band to be used to stretch the upper trapezius muscle in the desired direction.
• Conventional Physical Therapy
Conventional physical therapy will be consisted of hotpack, therapeutic ultrasound and tens applications.

Locations

Country	Name	City	State
Turkey	Yuzuncu Yil University	Van

Sponsors (1)

Lead Sponsor	Collaborator
Yuzuncu Yil University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analogue Scale (VAS)	patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome.	at baseline (before the treatment)
Primary	Visual Analogue Scale (VAS)	patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome	2 weeks after baseline (at the end of treatment)
Primary	Visual Analogue Scale (VAS)	patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome	6 weeks after baseline (one month after the end of treatment)
Primary	Neck Disability Index (NDI)	a self-report questionnaire used to determine how neck pain affects a patient's daily life and to assess the self-rated disability of patients with neck pain. The total score ranges from 0 (no disability) to 50 (total disability).	at baseline (before the treatment)
Primary	Neck Disability Index (NDI)	a self-report questionnaire used to determine how neck pain affects a patient's daily life and to assess the self-rated disability of patients with neck pain. The total score ranges from 0 (no disability) to 50 (total disability).	2 weeks after baseline (at the end of treatment)
Primary	Neck Disability Index (NDI)	a self-report questionnaire used to determine how neck pain affects a patient's daily life and to assess the self-rated disability of patients with neck pain. The total score ranges from 0 (no disability) to 50 (total disability).	6 weeks after baseline (one month after the end of treatment)
Secondary	Measurement of Cervical range of motion (Cervikal ROM)	Measuring cervical lateral flexion and cervical extension with a manual goniometer.	at baseline (before the treatment)
Secondary	Measurement of Cervical range of motion (Cervikal ROM)	Measuring cervical lateral flexion and cervical extension with a manual goniometer.	2 weeks after baseline (at the end of treatment).
Secondary	Measurement of Cervical range of motion (Cervikal ROM)	Measuring cervical lateral flexion and cervical extension with a manual goniometer.	6 weeks after baseline (one month after the end of treatment)